2 most recent filings and news items mentioning BRIA. Updated every 60 seconds.
EarningsJun 26, 2026Positive
BriaPro Therapeutics Corp. filed unaudited interim financial statements for the period ended April 30, 2026, showing a substantial increase in total assets. The filing highlights a significant improvement in liquidity to approximately $300,000 in cash and cash equivalents, contra
View filing at SEC.gov →
OfferingJun 3, 2026Neutral
BriaCell Therapeutics filed a warrant agreement allowing placement agents to purchase common shares starting June 2, 2026, expiring five years later per FINRA rules. The warrant issuance is typical financing activity for biotech companies seeking to incentivize capital raising in
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.